KETAmine Hydrochloride Injection, USP, 50 mg/5mL (10 mg/mL), For IM Use or Slow IV Use, 5 mL Sterile Single-Dose Vial, Rx Only, For Office Use Only, Compounded Durg by: Medivant Healthcare, 158 S. Kyrene Rd. Chandler, AZ 85226, NDC 81483-0006-0.
Published July 9, 2025 · Recall initiated: June 2, 2025
Summary
FDA records drug Class II recall D-0500-2025, published July 9, 2025 and initiated June 2, 2025. Recalling firm: Tailstorm Health INC; Status: Ongoing; Reported quantity: 23,200 vials; Lot: Lot #s: 2502008, Exp. 2/27/2027; 2503001, Exp. 3/4/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.
What to do
Voluntary: Firm initiated
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Tailstorm Health INC
- Distributor
- Nationwide in the US
- Lot
- Lot #s: 2502008, Exp. 2/27/2027; 2503001, Exp. 3/4/2027.
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDALIDOcaine HCL Sterile Injection, USP, 100mg/10mL, 1%, (10mg/mL), w/EPINEPHRINE 1:100,000, For Infiltration &July 9, 2025
- FDAKETAmine Hydrochloride Injection, USP, 500mg/5mL, (10mg/mL), For IM or Slow IV Use, 5mL Sterile Multi-DoseJuly 9, 2025
- FDABUPIVAcaine HCL Sterile injection, USP w/EPINEPHRINE 1:200,000, 50 mg/10mL, 0.5%, (5mg/mL), 10 mL SterileJuly 9, 2025
- FDALIDOcaine HCl Injection, USP, 10mg/mL, 1% (100 mg/10mL), 10 mL Sterile Single Dose Vial, Rx Only, ForJuly 9, 2025
- FDALIDOcaine HCL Sterile Injection, USP, 20 mg/mL, 2%, (200 mg/10 mL), For Infiltration & Nerve Block, IncludingJuly 9, 2025
- FDASpectral CT. Computed tomography X-ray system.July 2, 2025
Questions about this recall
Was KETAmine Hydrochloride Injection, USP, 50 mg/5mL (10 mg/mL), For IM Use or Slow IV Use, 5 mL Sterile Single-Dose Vial, Rx Only, For Office Use Only, Compounded Durg by: Medivant Healthcare, 158 S. Kyrene Rd. Chandler, AZ 85226, NDC 81483-0006-0. recalled?
Yes. FDA published recall D-0500-2025 on July 9, 2025. Reported hazard: Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.
What should I do if I have this product?
Voluntary: Firm initiated